SCHEMBL24240683

SCHEMBL24240683

CCCCCCCOc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR4 P22455 13/20 0.80
KDR P35968 5/20 0.80
FGFR1 P11362 4/20 0.80
RET P07949 3/20 0.80
PDGFRB P09619 3/20 0.80
PDGFRA P16234 3/20 0.80
FLT1 P17948 3/20 0.80
FLT4 P35916 3/20 0.80
FGFR2 P21802 3/20 0.80
FGFR3 P22607 3/20 0.80
KIT P10721 2/20 0.80
AURKB Q96GD4 2/20 0.80
RIPK2 O43353 1/20 0.80
ERN1 O75460 1/20 0.80
STK10 O94804 1/20 0.80
MAP3K6 O95382 1/20 0.80
ABL1 P00519 1/20 0.80
ESR1 P03372 1/20 0.80
ADORA3 P0DMS8 1/20 0.80
BCR P11274 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22521219 0.92 FGFR4 (0.77) FGFR4KDRFGFR1RETPDGFRB
SCHEMBL22521247 0.92 FGFR4 (0.77) FGFR4KDRFGFR1RETPDGFRB
SCHEMBL1899046 0.91 FGFR4 (0.81) FGFR4KDRFGFR1RETPDGFRB
SCHEMBL864029 0.91 FGFR4 (0.80) FGFR4KDRFGFR1RETPDGFRB
SCHEMBL864156 0.91 FGFR4 (0.85) FGFR4KDRFGFR1RETPDGFRB
SCHEMBL864110 0.91 FGFR4 (0.82) FGFR4KDRFGFR1RETPDGFRB
SCHEMBL22521245 0.90 FGFR4 (0.74) FGFR4KDRFGFR1RETPDGFRB
SCHEMBL22521206 0.90 FGFR4 (0.74) FGFR4KDRFGFR1RETPDGFRB
SCHEMBL12412057 0.90 FGFR4 (0.76) FGFR4KDRFGFR1RETPDGFRB
Lenvatinib SCHEMBL29349806 0.89 FGFR4 (1.00) FGFR4KDRFGFR1RETPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3950677-A1 QUINOLYL-CONTAINING COMPOUND AND PHARMACEUTICAL COMPOSITION, AND USE THEREOF Primegene (Beijing) Co., Ltd. (CN) 2022-02-09 EP disclosed